Carson Allaria Wealth Management, Ltd. Gilead Sciences, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $167 Million
- Q1 2025
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 120 shares of GILD stock, worth $13,210. This represents 0.01% of its overall portfolio holdings.
Number of Shares
120
Previous 120
-0.0%
Holding current value
$13,210
Previous $11,000
18.18%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.9 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.55 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.01 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.9 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...